Impact of imiglucerase supply shortage on clinical and laboratory parameters in Norrbottnian patients with Gaucher disease type 3

• Autorzy: Machaczka M. , Kampke Bjorkvall C. , Wieremiejczyk J. , Paucar Arce M. , Myhr-Eriksson K. , Klimowska M. , Hagglund H. , Svenningsson P.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

Gaucher disease; Norrbottnian type; clinical parameter; laboratory parameter; enzyme replacement therapy; imiglucerase; hemoglobin concentration; patient

• Wydawca: -
• Czasopismo: Archivum Immunologiae et Therapiae Experimentalis
• Rocznik: 2015
• Tom: 63
• Numer: 1
• Opis fizyczny: p.65-71,fig.,ref.

Twórcy

autor

Machaczka M.

• Medical Faculty, University of Rzeszow, 35-959 Rzeszow, Poland
• Hematology Center Karolinska and Department of Medicine at Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, M54, Stockholm, Sweden

autor

Kampke Bjorkvall C.

• Department of Medicine, Sunderby Regional Hospital of Norrbotten County, Lulea, Sweden

autor

Wieremiejczyk J.

• Department of Medicine, Sunderby Regional Hospital of Norrbotten County, Lulea, Sweden

autor

Paucar Arce M.

• Department of Neurology, Karolinska University Hospital Huddinge, Stockholm, Sweden
• Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

autor

Myhr-Eriksson K.

• Department of Medicine, Sunderby Regional Hospital of Norrbotten County, Lulea, Sweden

autor

Klimowska M.

• Department of Clinical Pathology and Cytology, Karolinska University Hospital Huddinge, Stockholm, Sweden

autor

Hagglund H.

• Hematology Center Karolinska and Department of Medicine at Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, M54, Stockholm, Sweden

autor

Svenningsson P.

• Department of Neurology, Karolinska University Hospital Huddinge, Stockholm, Sweden
• Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Identyfikatory

DOI

10.1007/s00005-014-0308-8